Skip to content

Clinical trials

Carcinoma, Renal Cell trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Country / region: Japan Clear all

69 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20052
20062
20072
20083
20093
20103
20112
20122
20141
20156
20164
20176
20183
20194
20205
20217
20224
20233
20242
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed36
Active, not recruiting12
Terminated12
Recruiting6
Unknown status3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals12
Pfizer12
Bristol-Myers Squibb9
Bayer6
Merck Sharp & Dohme LLC6
Hoffmann-La Roche4
GlaxoSmithKline2
Tokushukai Medical Group2
AbbVie1
AstraZeneca1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell69
Carcinoma, Non-Small-Cell Lung18
Kidney Neoplasms13
Melanoma12
Neoplasms10
Squamous Cell Carcinoma of Head and Neck10
Colorectal Neoplasms7
Ovarian Neoplasms7
Neoplasm Metastasis6
Triple Negative Breast Neoplasms5

Trials

Showing 1 to 25 of 69. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.